One important early contribution to the control of chemical carcinogenesis is provided by the enzyme pattern responsible for the generation and disposition of reactive metabolites. Especially well studied i s the important group of enzymes responsible for the control of reactive epoxides. Many natural as well as man-made foreign compounds, including pharmaceuticals, possess olefinic or aromatic double bonds. Such compounds can be transformed to epoxides by microsomal monooxygenases present in very many mammalian organs. By virtue of their electrophilic reactivity such epoxides may spontaneously react with nucleophilic centers in the cell and thus covalently bind to DNA, RNA, and protein. Such alterations of critical cellular macromolecules may disturb the normal biochemistry of the cell and lead to cytotoxic, allergenic, mutagenic, and/or carcinogenic effects. Whether such effects will be manifested depends on one hand on the chemical reactivity as well as other properties (geometry, lipophilicity) of the epoxide in question. On the other hand, enzymes controlling the concentration of such epoxides are another important contributing factor. Several rnicrosomal monooxygenases exist differing in activity and substrate specificity. With respect to large substrates, some monooxygenases preferentially attack at one specific site different from that attacked by others. Some of these pathways lead to reactive products, others are detoxification pathways. Moreover, enzymes metabolizing such epoxides represent a further determining factor. These enzymes include epoxide hydrolases and glutathione transferases.
INTKODUCTION
During the last two decades evidence has been accumulating that most chemical mu- 392 
OESCH
TOXICOLOGIC PATHOLOGY
MULTIPLE MONOOXYCENASES AND MICROSOMAL EPOXIDE HYDROLASE
Most carcinogen-metabolizing enzymes have proven to play dual roles in that they are involved in both activation and inactivation. Typically, individual enzymes predominantly play only one of these roles and the opposite role is restricted to defined exceptions. However, microsomal monooxygenases are responsible for very many activating and inactivating reactions (32) . A prime example is aromatic and olefinic structural elements which can be converted by polysubstrate monooxygenases into reactive epoxides (17, 26, 29) . There is a further set of enzymes which are capable of metabolizing these epoxides: epoxide hydrolases, which transform epoxides to chemically unreactive trans-dihydrodiols (13, 17, 26, 29) , glutathione transferases, which open the epoxide ring by the addition of glutathione (1, 17, 26, 29) ; epoxide reductases, which convert the derivative back to the mother compound (5, 33) . The enzymes are present in multiple forms which differ from each other in their substrate preferences. In larger molecules, they have their preferential site of attack which leads to various sets of reactive metabolites which are toxicologically different. Benzo(a)pyrene, taken as an example, is metabolized by monooxygenase to the reactive 7,8-oxide and this reactive compound is inactivated by microsomal epoxide hydrolase to the corresponding 7,8-dihydrodiol. This is, however, the precursor molecule for a second monooxygenation step, which reintroduces an epoxide moiety leading to a dihydrodiol bay region epoxide. According to chemical quantum calculations by Lehr and Jerina (20) ,
INDUCED REVERTANTS
this is especially chemically reactive and has been proven to be an ultimate carcinogen (19, 31) . Thus, a single enzyme can play a multiple role in inactivating some metabolites but producing precursors for other reactive species. Moreover, in many instances several reactive metabolites are involved in a given toxic response. They can be toxicologically different from one another, and, since they are reactive and short-lived, it is difficult in many cases to quantitate or characterize them chemically. Therefore, we monitored with various strains of bacteria the potency of certain synthetically prepared reactive metabolites to cause mutations. When the K region epoxide, benzo(a)pyrene 4,5-oxide, was monitored with TA 98 and TA 1537, strain 98 was somewhat more efficiently mutated by a factor of 1.6 (Fig. 1) . After in situ bioactivation of the chemically synthesized 7,8-dihydrodiol to the corresponding dihydrodiol bay region epoxide, strain TA 98 was much more efficiently reverted than TA 1537, by a factor of 15. This ratio was again different from that observed after in situ bioactivation of the g,lO-dihydrodiol, etc. So for various reactive metabolites which are derived from the same parent compound, there is a characteristic ratio of how various strains of bacteria are reverted. This ratio can be used to monitor which reactive metabolites have been predominantly responsible for the mutagenic effect in a complex metabolic situation.
When microsomal epoxide hydrolase which has been purified to apparent homogeneity (2) was added to benzo(a)pyrene activated by liver microsomes from untreated mice, the mutagenicity was decreased to 1-2% of the original rate and this could not be Vol. 12, No. 4, 1984 ENZYMES AND REACTIVE METABOLITES 393 further reduced by adding more enzyme. This remaining mutagenicity is due to the epoxide hydrolase-resistant portion of reactive metabolites. It was shown by means of the ratios of various strains that the K region 4,s-oxide was mainly responsible for the major (i.e., epoxide hydrolase-sensitive) portion of the mutagenic effect under these conditions. The situation was completely different when liver microsomes from mice pretreated with 3-methylcholanthrene were used, producing a different pat tern of monooxygenase isoenzymes. These create a different pattern of primary reactive metabolites and in this situation microsomal epoxide hydrolase has first a weak but activating effect (3) . This is because now dihydrodiol epoxides are predominantly responsible for the mutagenic effect. Since many metabolites and many enzymes with different K, values are measurably contributing to the control of the mutagenic metabolites, the effect is multiphasic. The microsomes used for creating the metabolites do themselves possess epoxide hydrolase and can generate dihydrodiol epoxides, but addition of more epoxide hydrolase leads to an (small but significant) increase of the mutagenicity, since more of these dihydrodiol epoxides are produced. If the amount of epoxide hydrolase is further increased, a small decrease and then a small increase of the mutagenicity takes place (3).
DIHYDRODIOL DEHYDROGENASE
When benzo(a)pyrene was activated by liver microsomes from S-methylcholanthrene-treated mice, addition of dihydrodiol dehydrogenase purified to apparent homogeneity (34) clearly reduced the mutagenicity (12). When using about 15 times more enzyme than that present in the amount of liver equivalent to the microsomes used for activation, maximal reduction of mutagenicity was achieved. Between various animal species (28, 35) or after exposure to foreign compounds with inducing properties (27) , similar or greater differences in activities of enzymes metabolizing xenobiotics have been observed. No effect of dihydrodiol dehydrogenase on the mutagenicity of benzo(a)pyrene was found when microsomes from control mice were used, in contrast to the experiments where microsomes from 3-methylcholanthrene-treated mice were used. Since control mouse liver microsomes activate benzo(a)pyrene more to benzo(a)pyrene 4,soxide than to vicinal dihydrodiol bay region epoxides (3, 28), this behavior is readily understandable.
The enzymic inactivation of vicinal diol epoxides, the metabolites of polycyclic hydocarbons that seem to be responsible for most of the carcinogenic and mutagenic effects induced by these compounds (15, 19, 21, 25, 30, 31) , is largely unexplored. Mutagenicity and DNA-binding experiments with trans-7,8-dihydro-7,8-dihydroxybenzo(a)pyrene indicate that some inactivation is caused by the presence of glutathione (10, 11, 14) but not by microsomal epoxide hydrolase (3). The inability of microsomal epoxide hydrolase to inactivate the anti isomer of the corresponding bay region diol epoxide and the very weak effect on the activity of the syn isomer (37) confirm the latter observation. These negative findings may result from the short half-life of the diol epoxide in a n aqueous environment, although this may not necessarily be the same in a biologic membrane. Not all vicinal diol epoxides are of low stability. The non-bay region diol epoxide, r-8, t-9-dihydroxy-t-l0,11-oxy-8,9,lO,l~-tetrahydrobenz(a)anthracene (BA-8,S-diol 10,ll-oxide), has a half-life of many hours and is therefore useful for metabolic studies. It is mutagenic (22, 36) and is often the major DNA-binding species formed from benz(a)anthracene in vivo and in vitro (6, 21, 36) , and it serves as a model for less stable diol epoxides. The results reported below show that a diol epoxide can be metabolically inactivated by dihydrodiol dehydrogenase but not by microsomal or cytosolic epoxide hydrolase. If one assumes that the activities of the investigated enzymes in vivo are comparable to those that are present in our experiments in vitro, inactivation of the diol epoxide by dihydrodiol dehydrogenase would be slower than the rate of inactivation of the K region oxide by microsomal epoxide hydrolase, but still sufficiently rapid to substantially affect diol epoxide concentrations in mammalian systems. To study their role in metabolic inactivation, the three enzymes, microsomal and cytosolic epoxide hydrolase and cytosolic dihydrodiol dehydrogenase, were purified and bacterial mutagenicity was used as a n indication of their effects on the mutagenicity of BA-8,S-diol 10,ll-oxide and benz(a)anthracene 5,6-oxide (BA 5,6-oxide), the K region epoxide (9). As expected from its substrate specificity (4, 18) , microsomal epoxide hydrolase readily inactivated BA 5,6- Neither microsomal nor cytosolic epoxide hydrolase inactivated the diol epoxide. However, the diol epoxide was inactivated by dihydrodiol dehydrogenase in a NADP-dependent reaction (Fig. 2) . Relatively large amounts of dihydrodiol dehydrogenase were required for inactivation of the diol epoxide, whereas a low concentration of microsomal epoxide hydrolase was sufficient for the inactivation of BA 5,6-oxide. A 50% inactivation of 1 p g of BA 5,G-oxide was achieved with either 0.4 units of purified rat microsoma1 epoxide hydrolase, equivalent to 1.3 mg of liver, or with 7 units of purified rabbit cytosolic epoxide hydrolase, equivalent to 28 mg of liver. These are relatively small quantities of enzyme. Microsomal epoxide hydrolase equivalent to 330 mg of rat liver and cytosolic epoxide hydrolase equivalent to 200 mg of rabbit liver did not inactivate this mutagen, whereas with dihydrodiol dehydrogenase an amount equivalent to 200 mg of liver was required to obtain a 50% inactivation (9). An effective but moderate rate of inactivation of vicinal diol epoxides suggests that differences in enzyme activity arc likely causes for differences in susceptibility to the effects of polycyclic aromatic hydrocarbons among species, organs, and physiological states.
GLUTATHIONE TRANSFERASES
The recently discovered glutathione transferase X (7) and the glutathione transferases A, B, and C, ivhich are the most abundant forms present in rat liver in terms of amounts of protein (I), have been purified to apparent homogeneity and investigated for their abilities to inactivate the two prototype epogides discussed above, BA 5,G-oxide and BA-83-diol 10,ll-oxide (10). The glutathione transferases A, B, C, and X inactivated the K region epoxide and the diol epoxide. About 1000-fold higher concentrations of glutathione transferase were required for inactivation of the diol epoxide than for inactivation of the K region epoxide. This was independent of the enzyme form used. These similarities in the ratio of inactivation of the two epoxides by the enzymes were remarkable because the enzymes differed substantially from each other in the efficiency with which they inactivated the epoxides. Form X was much more efficient than form C, which in turn was clearly more active than form A. Glutathione transferase B also inactivated the K region epoxide more efficiently than the diol epoxide; its activity toward the diol epoxide was similar to that of enzyme A (Fig. 3) .
CONCLUSION
The data taken together show that when intrinsic enzyme activities and the relative amounts of enzymes present in the liver are considered (but disregarding subcellular compartmentalization), the glutathione transferases can play a more important role in the inactivation of BA 5,6-oxide and BA-8,g-diol 10,1 I-oxide than dihydrodiol dehydrogenase or the epoxide hydrolases, although the latter are specific enzymes for the hydrolysis of epoxides. Among the glutathione transferases, large differences in efficiency of detoxification occur and this even holds true for the immunologically closely related forms A, C, and X (7,16), which differ in efficiency by more than an order of magnitude. With regard to the enzymes present in rat liver, the forms C and X appear to be able to contribute most to the inactivation of the two epoxides examined; form C because of its quantitative abundance in rat liver, and form X because it is able to inactivate these epoxides more efficiently. Obviously such an estimate is very crude, when different types of enzymes are compared, because of differences in cofactor concentration, in pH optima, and in other environmental factors which may lead to substantial differences between enzyme activity in vivo and under our experimental conditions. In spite of these limitations, the data presented here on the more efficient in vitro inactivation of epoxides by glutathione transferases than by the other enzymes indicate that it is quite likely that glutathione transferases also play an important role in the in vivo inactivation of epoxides derived from polycylic aromatic hydrocarbons.
